Journal ArticleNat Genet · March 4, 2025
Heart failure (HF) is a major contributor to global morbidity and mortality. While distinct clinical subtypes, defined by etiology and left ventricular ejection fraction, are well recognized, their genetic determinants remain inadequately understood. In th ...
Full textLink to itemCite
Journal ArticleJACC Basic Transl Sci · May 2024
The adult mammalian heart harbors minute levels of cycling cardiomyocytes (CMs). Large numbers of images are needed to accurately quantify cycling events using microscopy-based methods. CardioCount is a new deep learning-based pipeline to rigorously score ...
Full textLink to itemCite
Journal ArticleJ Card Fail · December 2023
BACKGROUND: A diagnosis of Lamin proteins A and C cardiomyopathy (LMNA-CM) not only impacts disease prognosis, but also leads to specific guideline-recommended treatment options for these patients. This etiology is fundamentally different from other geneti ...
Full textLink to itemCite
ConferenceCirculation · November 7, 2023
Background:
Higher plasma concentrations of angiopoietin 2 (ANGPT2) are associated with higher risk for hospitalization for heart failure (HF) and death in univariate analyses. However, the independen ...
Full textCite
Journal ArticleAm J Cardiol · October 1, 2023
Cardiac sarcoidosis (CS) is a relapsing-remitting disease, and immune suppression (IS) is the mainstay of therapy. Predictors of relapse for patients with CS in remission are not well characterized. We assessed incidence of relapse in consecutive patients ...
Full textLink to itemCite
Journal ArticleJ Card Fail · June 2023
BACKGROUND: We sought to determine whether circulating modifiers of endothelial function are associated with cardiac structure and clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF). METHODS: We measured 25 proteins rel ...
Full textLink to itemCite
Journal ArticleDis Model Mech · May 1, 2023
Summary: This Editorial introduces DMM's new Special Issue on ‘Moving heart failure to heart success’. The Guest Editors reflect on how articles in the issue advance the cardiac research field. ...
Full textLink to itemCite
Journal ArticleCell Stem Cell · January 5, 2023
The efficacy and safety of gene-therapy strategies for indications like tissue damage hinge on precision; yet, current methods afford little spatial or temporal control of payload delivery. Here, we find that tissue-regeneration enhancer elements (TREEs) i ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 2022
Human cardiac organoid systems hold significant promise for mechanistic studies of early heart morphogenesis and an improved understanding of congenital cardiac disease. ...
Full textLink to itemCite
Journal ArticleCurr Allergy Asthma Rep · December 2022
PURPOSE OF REVIEW: Cardiac sarcoidosis (CS) is an important cause of non-ischemic cardiomyopathy and has specific diagnostic and therapeutic considerations. With advances in imaging techniques and treatment approaches, the approach to monitoring disease pr ...
Full textLink to itemCite
Journal ArticleDevelopment · September 15, 2022
Heart regeneration requires multiple cell types to enable cardiomyocyte (CM) proliferation. How these cells interact to create growth niches is unclear. Here, we profile proliferation kinetics of cardiac endothelial cells (CECs) and CMs in the neonatal mou ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · August 2022
BACKGROUND: The significance of recovered left ventricular ejection fraction (LVEF) in LVAD recipients, outside of pump explantation, is unclear. METHODS: Patients undergoing first LVAD implantation at Duke University Hospital between 2006 and 2017 were ev ...
Full textLink to itemCite
Journal ArticleCirculation · April 19, 2022
BACKGROUND: Heart failure (HF) is a highly prevalent disorder for which disease mechanisms are incompletely understood. The discovery of disease-associated proteins with causal genetic evidence provides an opportunity to identify new therapeutic targets. M ...
Full textLink to itemCite
Journal ArticleIEEE Trans Biomed Eng · October 2021
OBJECTIVE: LVADs are surgically implanted mechanical pumps that improve survival rates of individuals with advanced heart failure. LVAD therapy is associated with high morbidity, which can be partially attributed to challenges with detecting LVAD complicat ...
Full textLink to itemCite
Journal ArticleEur J Heart Fail · July 2021
AIMS: Nitroxyl provokes vasodilatation and inotropic and lusitropic effects in animals via post-translational modification of thiols. We aimed to compare effects of the nitroxyl donor cimlanod (BMS-986231) with those of nitroglycerin (NTG) or placebo on ca ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · March 16, 2021
Background Although technological advances to pump design have improved survival, left ventricular assist device (LVAD) recipients experience variable improvements in quality of life. Methods for optimizing LVAD support to improve quality of life are neede ...
Full textLink to itemCite
Journal ArticleCurr Cardiol Rep · March 2, 2021
PURPOSE OF REVIEW: The replenishment of lost or damaged myocardium has the potential to reverse heart failure, making heart regeneration a goal for cardiovascular medicine. Unlike adult mammals, injury to the zebrafish or neonatal mouse heart induces a rob ...
Full textLink to itemCite
Chapter · 2021
The epicardium is a multipotent cell layer that is vital to myocardial development and regeneration. Epicardial cells contribute to cardiac fibroblast and smooth muscle populations of the heart and secrete paracrine factors that promote cardiomyocyte proli ...
Full textLink to itemCite
Journal Article · 2021
ABSTRACTBackground Heart regeneration requires multiple cell types to enable cardiomyocyte (CM) proliferation. How these cells interact to create growth niches is unclear. Here we profile proliferation kinetics of cardiac endothelial cel ...
Full textCite
ConferenceBHI 2021 - 2021 IEEE EMBS International Conference on Biomedical and Health Informatics, Proceedings · January 1, 2021
Warfarin, a commonly prescribed drug to prevent blood clots, has a highly variable individual response. Determining a maintenance warfarin dose that achieves a therapeutic blood clotting time, as measured by the international normalized ratio (INR), is cru ...
Full textCite
ConferenceComputing in Cardiology · September 13, 2020
The left ventricular assist device (LVAD) has emerged as a bridge or alternative to heart transplant in individuals with advanced heart failure. However, the LVAD recipient population currently faces high rehospitalization rates. Remote analysis of precord ...
Full textCite
Journal ArticleEur J Heart Fail · September 2020
AIMS: Both left ventricular (LV) and left atrial (LA) dysfunction and remodelling contribute to adverse outcomes in heart failure with reduced ejection fraction (HFrEF). Danicamtiv is a novel, cardiac myosin activator that enhances cardiomyocyte contractio ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · September 2020
OBJECTIVES: This study characterized the relationship between conduction disease and cardiac amyloidosis (CA) through longitudinal analysis of cardiac implantable electronic device (CIED) data. BACKGROUND: Bradyarrhythmias and tachyarrhythmias are commonly ...
Full textLink to itemCite
Journal ArticleJ Vis Exp · August 22, 2020
By replacing lost or dysfunctional myocardium, tissue regeneration is a promising approach to treat heart failure. However, the challenge of detecting bona fide heart regeneration limits the validation of potential regenerative factors. One method to detec ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Transl Res · April 2020
We evaluated the heterogeneity of outcomes among heart failure patients with ventricular recovery. The BEST trial studied patients with left ventricular ejection fraction (LVEF) ≤ 35%. Serial LVEF assessment was performed at baseline, 3 months, and 12 mont ...
Full textLink to itemCite
Journal ArticleElife · November 8, 2019
In recent years, there has been increasing interest in the role of lymphatics in organ repair and regeneration, due to their importance in immune surveillance and fluid homeostasis. Experimental approaches aimed at boosting lymphangiogenesis following myoc ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · November 5, 2019
Background DNA methylation is implicated in many chronic diseases and may contribute to mortality. Therefore, we conducted an epigenome-wide association study (EWAS) for all-cause mortality with whole-transcriptome data in a cardiovascular cohort (CATHGEN ...
Full textLink to itemCite
Journal ArticleJ Eng Sci Med Diagn Ther · May 2019
Left ventricular assist devices (LVADs) are life-saving, surgically implanted mechanical heart pumps used to treat patients with advanced heart failure (HF). While life-saving, LVAD support is associated with a high incidence of complications, making early ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Dev Dis · December 11, 2018
Studies over the past two decades have shown heart regeneration in zebrafish to be a dynamic process, choreographed by multiple cell types. In particular, recent work has identified revascularization of the wound to be a sentinel event during heart regener ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · August 28, 2018
During heart development and regeneration, coronary vascularization is tightly coupled with cardiac growth. Although inhibiting vascularization causes defects in the innate regenerative response of zebrafish to heart injury, angiogenic signals are not know ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · August 1, 2017
Coronary revascularization is an effective means of treating ischemic heart disease; however, current therapeutic revascularization strategies are limited to large caliber vessels. Because the mammalian heart scars following cardiac injury, recent work sho ...
Full textLink to itemCite
Journal ArticleDev Cell · February 27, 2017
Chromatin regulation is a principal mechanism governing animal development, yet it is unclear to what extent structural changes in chromatin underlie tissue regeneration. Non-mammalian vertebrates such as zebrafish activate cardiomyocyte (CM) division afte ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · February 1, 2017
Heart failure is a major source of morbidity and mortality. Replacing lost myocardium with new tissue is a major goal of regenerative medicine. Unlike adult mammals, zebrafish and neonatal mice are capable of heart regeneration following cardiac injury. In ...
Full textLink to itemCite
Journal ArticleNature · April 14, 2016
How tissue regeneration programs are triggered by injury has received limited research attention. Here we investigate the existence of enhancer regulatory elements that are activated in regenerating tissue. Transcriptomic analyses reveal that leptin b (lep ...
Full textLink to itemCite
Journal ArticleDevelopment · January 15, 2016
In contrast to mammals, adult zebrafish have a high capacity to regenerate damaged or lost myocardium through proliferation of cardiomyocytes spared from damage. The epicardial sheet covering the heart is activated by injury and aids muscle regeneration th ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · October 27, 2015
Heart regeneration offers a novel therapeutic strategy for heart failure. Unlike mammals, lower vertebrates such as zebrafish mount a strong regenerative response following cardiac injury. Heart regeneration in zebrafish occurs by cardiomyocyte proliferati ...
Full textLink to itemCite
Journal ArticleDev Cell · June 22, 2015
In this issue of Developmental Cell, Iyengar and colleagues (2015) employ live imaging of melanocyte regeneration in adult zebrafish to define a bias in progenitor cell fates that enables both rapid pigment cell renewal and maintenance of regenerative capa ...
Full textLink to itemCite
Journal ArticleElife · April 1, 2015
Featured Publication
Heart regeneration is limited in adult mammals but occurs naturally in adult zebrafish through the activation of cardiomyocyte division. Several components of the cardiac injury microenvironment have been identified, yet no factor on its own is known to st ...
Full textOpen AccessLink to itemCite
Chapter · January 1, 2015
The mediastinum is the space in the thorax between the lungs; it houses the heart, great vessels, esophagus, trachea, thymus, and lymph nodes. The connective tissues of the mediastinum are continuous with the long fascial planes of the head and neck, one r ...
Full textCite
Journal ArticleDev Biol · October 15, 2013
Unlike adult mammals, adult zebrafish vigorously regenerate lost heart muscle in response to injury. The epicardium, a mesothelial cell layer enveloping the myocardium, is activated to proliferate after cardiac injury and can contribute vascular support ce ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · August 13, 2013
Certain lower vertebrates like zebrafish activate proliferation of spared cardiomyocytes after cardiac injury to regenerate lost heart muscle. Here, we used translating ribosome affinity purification to profile translating RNAs in zebrafish cardiomyocytes ...
Full textLink to itemCite
Journal ArticleCurr Biol · July 8, 2013
A common principle of tissue regeneration is the reactivation of previously employed developmental programs. During zebrafish heart regeneration, cardiomyocytes in the cortical layer of the ventricle induce the transcription factor gene gata4 and prolifera ...
Full textLink to itemCite
Journal ArticleCirc Res · March 15, 2013
RATIONALE: Cardiogenesis is regulated by a complex interplay between transcription factors. However, little is known about how these interactions regulate the transition from mesodermal precursors to cardiac progenitor cells (CPCs). OBJECTIVE: To identify ...
Full textLink to itemCite
Journal ArticleCirc Res · June 22, 2012
RATIONALE: Direct reprogramming of fibroblasts into cardiomyocytes is a novel strategy for cardiac regeneration. However, the key determinants involved in this process are unknown. OBJECTIVE: To assess the efficiency of direct fibroblast reprogramming via ...
Full textLink to itemCite
Journal Article · January 1, 2010
The mediastinum is defined as the space in the thorax between the lungs; it houses the heart, great vessels, esophagus, trachea, thymus, and lymph nodes. The connective tissues of the mediastinum are continuous with the long fascial planes of the head and ...
Full textCite
Journal ArticleRegen Med · March 2008
The potential for stem cells to ameliorate or cure heart diseases has galvanized a cadre of cardiovascular translational and clinical scientists to take a 'first-in-man' approach using autologous stem cells from a variety of tissues. However, recent clinic ...
Full textLink to itemCite
Journal ArticleDrug Discov Today Ther Strateg · 2008
Restoration of cardiovascular function is the ultimate goal of stem cell-based therapy. In principle, cardiovascular stem cells can improve cardiac function via de novo cardiomyogenesis, enhanced myocardial neovascularization, and prevention of post-infarc ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · September 2006
OBJECTIVE: Postoperative mediastinitis after median sternotomy is associated with disability and mortality. The aim of this study was to identify risk factors for mortality 1 year after postoperative mediastinitis diagnosis. METHODS: Postoperative mediasti ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · November 15, 2005
Atherosclerosis is a chronic inflammatory process and progresses through characteristic morphologic stages. We have shown previously that chronically injecting bone-marrow-derived vascular progenitor cells can effect arterial repair. This repair capacity d ...
Full textLink to itemCite